SCHUYLER WILLIAMS: Open Payments
NPI 1891394557 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 39 payments from 12 companies in 2025. Trend: 2023 $1,575 · 2024 $1,229 · 2025 $783
Food & beverage: $783
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $172 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $130 |
| Viatris Specialty LLC | 3 | $96 |
| JAZZ PHARMACEUTICALS INC. | 2 | $45 |
| Grifols USA, LLC | 1 | $28 |
| Verona Pharma, Inc. | 1 | $27 |
| HARMONY BIOSCIENCES LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $17 |
Products named: LUMRYZ, TRELEGY ELLIPTA, FASENRA, YUPELRI, NUCALA, BREZTRI, XYWAV, DUPIXENT.
Industry payments across NC — which companies pay providers there.
